TILT Holdings (TLLTF) Change in Receivables (2021 - 2025)
TILT Holdings (TLLTF) reported Change in Receivables of -$5.4 million for Q2 2025, up 19.21% on a YoY basis from -$4.6 million in Q2 2024, and down 1077.88% quarter-over-quarter from $556000.0 in Q1 2025.
TILT Holdings (TLLTF) Change in Receivables (2021 - 2025) Analysis & Trends
TILT Holdings has reported Change in Receivables for 5 years, with the latest figure at -$5.4 million in Q2 2025.
- For the quarter ending Q2 2025, Change in Receivables rose 19.21% year-over-year to -$5.4 million; the trailing twelve-month figure through Jun 2025 stood at -$4.3 million (up 70.48% YoY), and the FY2024 full-year result was -$6.3 million, up 22.06% from the prior year.
- Change in Receivables for Q2 2025 stood at -$5.4 million, down from $556000.0 in the prior quarter.
- The five-year high for Change in Receivables was $12.5 million in Q4 2021, with the low at -$6.7 million in Q2 2024.
- Historically, Change in Receivables has averaged -$311937.5 across 5 years, with a median of -$271000.0 in 2023.
- Annual changes were most pronounced in 2024 — Change in Receivables plunged 3923.86% — and 2025, when it soared 552.03%.
- TILT Holdings' Change in Receivables stood at $12.5 million in 2021, then plunged by 77.57% to $2.8 million in 2022, then slumped by 196.58% to -$2.7 million in 2023, then jumped by 151.29% to $1.4 million in 2024, then sank by 491.43% to -$5.4 million in 2025.
- The last three Change in Receivables figures came in at -$5.4 million (Q2 2025), $556000.0 (Q1 2025), and $1.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn | -5.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -5.44 Mn |
| Jun 30, 2025 | -5.44 Mn |
| Mar 31, 2025 | 556,000.00 |
| Mar 31, 2025 | 556,000.00 |
| Dec 31, 2024 | 1.39 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | -851,000.00 |
| Sep 30, 2024 | -851,000.00 |
| Jun 30, 2024 | -6.73 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Mar 31, 2024 | -123,000.00 |
| Mar 31, 2024 | -123,000.00 |
| Dec 31, 2023 | -2.71 Mn |
| Dec 31, 2023 | -2.71 Mn |
| Sep 30, 2023 | -5.15 Mn |
| Sep 30, 2023 | -5.15 Mn |
| Jun 30, 2023 | 176,000.00 |
| Jun 30, 2023 | 176,000.00 |
| Mar 31, 2023 | -419,000.00 |
| Mar 31, 2023 | -419,000.00 |